[1] Gandra S, Barter DM, Laxminarayan R.Economic burden of antibiotic resistance: how much do we really know?[J]. Clin Microbiol Infect, 2014, 20(10): 973-980. [2] Fitchett JR, Atun R.Antimicrobial resistance: opportunity for Europe to establish global leadership[J]. Lancet Infect Dis, 2016, 16(4): 388-389. [3] Liu YN, Zhang YJ, Hu MM, et al.Antimicrobial stewardship in developed countries[J]. Chinese Journal of New Drugs(中国新药杂志), 2014, 23(15): 1836-1842. [4] Xu XR, Sun Q, Yin J, et al.Policy evolution of China’s antibiotic resistance governance and its enlightenment[J]. Chinese Journal of Health Policy(中国卫生政策研究), 2019, 12(5): 38-43. [5] Yin XX, Wu SL, Tu XC, et al.Research status of antimicrobial drugs management policy in China[J]. Chinese Journal of Social Medicine(中国社会医学杂志), 2014, 31(1): 3-5. [6] Liu YQ, Sun Q, Yin J, et al.Policy evolution of antibiotic resistance governance in China and its implication[J]. Chinese Journal of Health Policy(中国卫生政策研究), 2019, 12(5): 44-48. [7] Xiao YH.Hierarchical management of antimicrobials: theory and practice[J]. Beijing Medical Journal(北京医学), 2012, 34(6): 486-489. [8] Hong Y, Liu X, Zhou Y, et al.Application of project management in AMS work in Peking University First Hospital[J]. Chinese Hospital Management(中国医院管理), 2019, 39(6): 44-45. [9] Wang Y, Tian J, Tan YB, et al.Comparative analysis of antimicrobial stewardship programs at home and abroad and enlightenment for China[J]. Chinese Journal of Nosocomiology(中华医院感染学杂志), 2018, 28(18): 2829-2833, 2838. [10] Lee CF, Cowling BJ, Feng S, et al.Impact of antibiotic stewardship programmes in Asia: a systematic review and meta-analysis[J]. J Antimicrob Chemother, 2018, 73(4): 844-851. [11] Guan LY, He XJ, Yu Y, et al.Analysis the management strategies and applications of antibiotics in our hospital[J]. The Chinese Journal of Clinical Pharmacology(中国临床药理学杂志), 2013, 29(5): 386-388. [12] Walker AJ, Curtis HJ, Goldacre B.Impact of chief medical officer activity on prescribing of antibiotics in England: an interrupted time series analysis[J]. J Antimicrob Chemother, 2019, 74(4): 1133-1136. [13] Balinskaite V, Johnson AP, Holmes A, et al.The impact of a national antimicrobial stewardship program on antibiotic prescribing in primary care: an interrupted time series analysis[J]. Clin Infect Dis, 2019, 69(2): 227-232. [14] Hersh AL, De LSA, Thurm C, et al.Antimicrobial stewardship programs in freestanding children's hospitals[J]. Pediatrics, 2015, 135(1): 33-39. [15] Zhu RL.Analysis of the effect of clinical pharmacy on the rational use of antibiotics[J]. China Practical Medicine(中国实用医药), 2015, 10(20): 185-186. [16] Zheng L.Study on clinical application and management of antibiotics in general hospital[J]. China Journal of Modern Medicine(中国现代医学杂志), 2012, 35(22): 110-112. [17] Ma XD, Hu RR, Jiao YH, et al.Comparison of clinical application management system of antibiotics between China and Sweden[J]. Herald of Medicine(医药导报), 2013, 32(10): 1381-1384. [18] Penm J, Li Y, Zhai S, et al.The impact of clinical pharmacy services in China on the quality use of medicines: a systematic review in context of China’s current healthcare reform[J]. Health Policy and Planning, 2013, 29(7): 849-872. [19] Çakmakçi M.Antibiotic stewardship programmes and the surgeon's role[J]. J Hosp Infect, 2015, 89(4): 264-266. [20] Dingle KE, Didelot X, Quan TP, et al.Effects of control interventions on Clostridium difficile infection in England: an observational study[J]. Lancet Infect Dis, 2017, 17(4): 411-421. [21] Karanika S, Paudel S, Grigoras C, et al.Systematic review and meta-analysis of clinical and economic outcomes from the implementation of hospital-based antimicrobial stewardship programs[J]. AntimicrobAgents Chemother, 2016, 60(8): 4840-4852. [22] Wu QZ, Wu WY, Zhu L, et al.Management effect on prophylactic use of antimicrobial agents during perioperative period of clean incision operations[J]. Chinese Journal of Infection Control(中国感染控制杂志), 2012, 11(1): 32-36. [23] Pei LS, Qi W, Wei DJ, et al.Changes in the antibiotic resistance rates of Klebsiella pneumoniae before and after the implementation of special antibacterial drug management system[J]. Chinese Journal of Nosocomiology(中华医院感染学杂志), 2015, 25(4): 825-826,838. [24] Wang H, Wang H, Yu X, et al.Impact of antimicrobial stewardship managed by clinical pharmacists on antibiotic use and drug resistance in a Chinese hospital, 2010~2016: a retrospective observational study[J]. BMJ Open, 2019, 9(8): e026072. [25] Wu G, Gong S, Cai H, et al.The availability, price and affordability of essential antibacterials in Hubei province, China[J]. BMC Health Serv Res, 2018, 18(1): 1013. [26] Bao L, Peng R, Wang Y, et al.Significant reduction of antibiotic consumption and patients' costs after an action plan in China, 2010~2014[J]. PLoS ONE, 2015, 10(3): e0118868. [27] Han E, Chae SM, Kim NS, et al.Effects of pharmaceutical cost containment policies on doctors' prescribing behavior: focus on antibiotics[J]. Health Policy, 2015, 119(9): 1245-1254. [28] Ruiz-Ramos J, Frasquet J, Romá E, et al.Cost-effectiveness analysis of implementing an antimicrobial stewardship program in critical care units[J]. J Med Econ, 2017, 20(6): 652-659. [29] Xing Y, Li X.Research progress and enlightenment on domestic and overseas antimicrobial stewardship programs[J]. Chinese Health Service Management(中国卫生事业管理), 2017, 34(6): 439-442. |